Genetic Testing (PGT/PGD) in Gurgaon: A Complete Clinical Guide for Couples Seeking Healthier Pregnancies

Preimplantation Genetic Testing (PGT) is an umbrella term for a group of tests performed on embryos created through IVF before they are transferred into the uterus. Its core goal is to identify embryos that are chromosomally or genetically normal, thereby improving the likelihood of a successful, healthy pregnancy.

PGT has three main subtypes. PGT-A (formerly PGS) screens for aneuploidy — an abnormal number of chromosomes — which is the most common cause of IVF failure and early miscarriage. PGT-M (formerly PGD) tests for specific single-gene or monogenic disorders such as thalassaemia, cystic fibrosis, spinal muscular atrophy, or BRCA1/BRCA2 mutations. PGT-SR tests for structural chromosomal rearrangements such as translocations that one or both parents may carry.

The distinction matters clinically. A couple in Gurgaon with no known family disease but multiple failed transfers may need PGT-A, while a couple where one partner carries a thalassaemia mutation — common in certain communities across Haryana — would benefit specifically from PGT-M. HomeIVF's genetic counsellors help families understand which test is appropriate for their unique profile before any cycle begins, ensuring that the testing approach is always purpose-driven and not a default add-on.

Not every IVF patient requires PGT, but specific clinical indications make it strongly advisable. Understanding these helps Gurgaon couples make informed decisions rather than feel pressured into unnecessary procedures.

Advanced maternal age is the single strongest indicator. Women above 35, and especially above 38, produce a significantly higher proportion of chromosomally abnormal eggs. Couples in high-pressure professional environments along Golf Course Road or in the corporate hubs near DLF Phase 4 and Phase 5 often delay conception, making age-related aneuploidy a real concern by the time they seek fertility treatment.

Recurrent pregnancy loss — defined as two or more consecutive miscarriages — is another primary indication. Studies show that up to 60% of early miscarriages are caused by chromosomal abnormalities in the embryo, making PGT-A a valuable investigative and preventive tool. Couples who have experienced two or more failed IVF cycles with good-quality embryos should also discuss PGT-A with their specialist.

Carriers of known genetic mutations, those with a family history of X-linked disorders, or couples where either partner has a chromosomal translocation are ideal candidates for PGT-M or PGT-SR respectively. Men with severe male factor infertility — especially non-obstructive azoospermia — have higher rates of chromosomal abnormalities in sperm-derived embryos, making PGT-A relevant for them too.

HomeIVF's intake assessment, conducted remotely with Gurgaon patients, includes a structured genetic risk questionnaire to identify these indications systematically before recommending any workup.

Understanding exactly what happens at each stage of PGT helps reduce anxiety and helps patients engage more confidently with their care team.

The process begins with a standard IVF stimulation cycle. The woman receives hormonal injections to stimulate the ovaries to produce multiple eggs. These eggs are retrieved, fertilised in the laboratory using conventional IVF or ICSI, and then cultured to the blastocyst stage — typically Day 5 or Day 6. Blastocyst-stage biopsy is significantly more accurate than Day 3 biopsy because more cells are sampled from the trophectoderm (the outer cell layer that becomes the placenta), reducing the risk of misdiagnosis.

A trained embryologist removes 5-8 trophectoderm cells from each blastocyst without damaging the inner cell mass, which develops into the baby. The biopsied embryos are vitrified (frozen) immediately to preserve their quality while the genetic analysis is conducted. Cells are sent to an accredited genetics laboratory — several of which have partnerships with Gurgaon's leading fertility centres — and analysed using Next Generation Sequencing (NGS), the current gold standard for PGT-A.

Results typically arrive within 10-14 working days. A genetic counsellor then reviews findings with the couple, classifying each embryo as euploid (normal), aneuploid (abnormal), or mosaic (mixed). Only euploid embryos are recommended for transfer in a subsequent frozen embryo transfer (FET) cycle, which is usually scheduled 4-6 weeks after the biopsy cycle. HomeIVF coordinates this entire pathway for Gurgaon patients, including home-based hormone monitoring to minimise unnecessary hospital visits.

Before initiating a PGT cycle, a thorough diagnostic workup is essential to confirm candidacy, rule out other treatable causes of failure, and design the most efficient stimulation protocol.

For women, baseline investigations include antral follicle count (AFC) via transvaginal ultrasound, serum AMH (Anti-Müllerian Hormone) to assess ovarian reserve, Day 2 or Day 3 FSH and estradiol levels, and a uterine cavity assessment via saline infusion sonography or hysteroscopy. Women with recurrent losses should also be screened for thrombophilias such as antiphospholipid syndrome, which can independently cause implantation failure even with euploid embryos.

For men, a detailed semen analysis with DNA fragmentation index (DFI) is critical. High sperm DNA fragmentation — common in men with sedentary lifestyles or chronic stress, patterns seen across Gurgaon's corporate population — can compromise embryo quality even when PGT-A identifies a chromosomally normal embryo. A DFI above 25-30% often warrants TESA/testicular sperm extraction to improve outcomes.

Both partners should undergo karyotyping if PGT-SR or PGT-M is being considered. For PGT-M specifically, the couple's genetic mutation must be characterised in advance by a molecular genetics laboratory, and probe development can take 6-8 weeks — a timeline Gurgaon patients near Sohna Road or Sector 56 should factor into their planning. HomeIVF's coordinators help schedule these investigations efficiently through a network of accredited diagnostic labs across Gurgaon, often with home sample collection.

HomeIVF does not replace the clinical infrastructure of an IVF laboratory — PGT requires physical embryo biopsy and laboratory analysis. What HomeIVF does is deliver senior-specialist-level fertility care at every stage that can be managed remotely or at home, significantly reducing the burden on Gurgaon patients.

This includes initial teleconsultation with experienced reproductive medicine specialists to assess candidacy for PGT, coordinating genetic counselling sessions, guiding patients through injectable stimulation protocols with home-based injection support, and facilitating at-home hormone monitoring (blood draws by certified phlebotomists visiting your home in areas like DLF Phase 1, DLF Phase 2, Golf Course Road, or Sohna Road).

HomeIVF also offers comprehensive IVF packages starting from ₹1.5 lakh, which can be customised to include PGT-A or PGT-M based on a patient's specific clinical indication. Package components are discussed transparently during the initial consultation so couples understand exactly what is covered, with no hidden costs.

For couples who have already been diagnosed at a Gurgaon clinic and need a second opinion on embryo selection strategy or PGT results interpretation, HomeIVF's Medical Board provides detailed case reviews. This ensures that patients from across the Gurgaon–Haryana belt — regardless of their proximity to a major hospital — have access to expert guidance that matches the quality available in top metropolitan fertility centres.

One of the most common questions from Gurgaon patients is: how long will this take, and is it financially feasible? Honest answers to both are essential for realistic planning.

From the first consultation to embryo transfer, a full PGT-A cycle typically spans 10-14 weeks. This includes: 2-3 weeks for preparatory investigations and cycle planning, 10-14 days of ovarian stimulation, the egg retrieval and fertilisation process (Days 1-6), 10-14 days for biopsy result return, and then a subsequent FET cycle 4-6 weeks later. Couples requiring PGT-M face a longer preparation phase — up to 8 weeks additional — for mutation characterisation and probe development, meaning the full journey may extend to 5-6 months from first consult to transfer.

Gurgaon's fertility treatment market is competitive, but costs for PGT cycles at reputable centres are meaningful. PGT-A adds laboratory and genetics costs to a standard IVF cycle, and the number of embryos tested affects the total. It is important for couples to request itemised quotes from any centre and to clarify whether genetic counselling, embryo vitrification, and the FET cycle are included.

HomeIVF's care coordinators help Gurgaon patients build a realistic financial and logistical roadmap, including guidance on EMI options available through partner financial institutions and on which components of the cycle may be eligible for corporate insurance coverage — a relevant point for the large number of MNC employees based along Golf Course Road and DLF Cyber City.

One of the most underappreciated stressors of an IVF-PGT cycle is the sheer number of clinic visits required. For Gurgaon professionals commuting daily — or working from home in DLF Phase 5 or Sector 56 — frequent morning visits to a fertility clinic for blood draws and ultrasounds are logistically challenging and emotionally disruptive.

HomeIVF addresses this directly. During the stimulation phase, certified phlebotomists visit the patient's home for blood hormone monitoring (oestradiol, LH, progesterone), with results shared securely through the HomeIVF platform within hours. Stimulation dose adjustments are communicated same-day by the clinical team, replicating the responsiveness of a premium fertility clinic without requiring the patient to travel.

During the FET preparation phase — when endometrial lining is built using oestrogen and progesterone — serial endometrial thickness monitoring is needed. HomeIVF coordinates transvaginal ultrasound home visits where clinically feasible, or directs patients to conveniently located empanelled scan centres nearest to their locality in Gurgaon.

This model reduces the number of in-clinic visits from a potential 8-12 per cycle to as few as 3-4 critical appointments (egg retrieval, embryo transfer, and any mandatory in-person assessments), dramatically improving the overall patient experience. For couples managing work, family, and the emotional weight of fertility treatment simultaneously, this difference is clinically and practically significant.

Despite Gurgaon's status as one of India's most developed urban centres, specific barriers prevent many couples from accessing PGT in a timely and effective manner. HomeIVF was designed with these barriers in mind.

Information asymmetry is a significant problem. Many couples undergo two or three failed IVF cycles without ever being offered PGT because the recommending clinician did not identify the clinical indication, or because PGT was presented as optional without adequate explanation of its potential benefit. HomeIVF's structured intake assessment and genetic risk profiling ensure that no eligible patient is overlooked.

Geographic clustering of fertility services is another barrier. Most premium fertility clinics in Gurgaon are concentrated near Sector 29, MG Road, or Cyber Hub areas. Couples living in peripheral localities such as Sohna Road extension, Palam Vihar, or Sectors 56-58 in Haryana face longer travel times and practical difficulties scheduling early-morning monitoring appointments around work.

Stigma and privacy concerns remain real in many Gurgaon households, where fertility treatment — and genetic testing in particular — may not yet be openly discussed. HomeIVF's home-based care model offers a layer of discretion that matters deeply to many families.

Finally, fragmented care — where a patient sees a gynaecologist, a fertility specialist, and a genetics counsellor at three different centres — leads to coordination failures. HomeIVF consolidates this through a single care team reviewed by the HomeIVF Medical Board, ensuring continuity, documentation, and seamless clinical decision-making for every Gurgaon patient we serve.